B. Matthew Joyce - Concepedia

Author

B. Matthew Joyce

University of Kentucky

Also Known As

B. Matthew Joyce, Barry M. Joyce

Publications

163

Citations

H-Index

Concepts

All Affiliations

University of Kentucky Albert B. Chandler Hospital Texas Tech University

About

B. Matthew Joyce is an author at University of Kentucky specializing in medicine, neuroscience, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	114
2	Neuroscience	4	4	104
3	Social Sciences	3	3	87
4	Health Sciences	1	1	17
5	Neurology	1	1	17

B. Matthew Joyce

Publications

163

Citations

H-Index

Page 1

	Year	Citations
Dopamine D4 receptor knockout mice exhibit neurochemical changes consistent with decreased dopamine release Theresa Currier Thomas, Paul J. Kruzich, B. Matthew Joyce, Journal of Neuroscience Methods Decreased Dopamine ReleaseMolecular NeuroscienceMedicineNeurotransmitterPsychopharmacology	2007	38
N,N′-Alkane-diyl-bis-3-picoliniums as Nicotinic Receptor Antagonists: Inhibition of Nicotine-Evoked Dopamine Release and Hyperactivity Linda P. Dwoskin, Thomas E. Wooters, Sangeetha P. Sumithran, Journal of Pharmacology and Experimental Therapeutics	2008	38
Adderall® produces increased striatal dopamine release and a prolonged time course compared to amphetamine isomers B. Matthew Joyce, Paul E.A. Glaser, Greg A. Gerhardt Psychopharmacology Prolonged Time CoursePsychoactive DrugAddictionMedicinePsychopharmacology	2006	26
Differential effects of amphetamine isomers on dopamine release in the rat striatum and nucleus accumbens core Paul E.A. Glaser, Theresa Currier Thomas, B. Matthew Joyce, Psychopharmacology NeuropsychologyPsychopharmacologySocial SciencesAmphetamine IsomersNeurochemistry	2004	23
Bilateral effects of unilateral intrastriatal GDNF on locomotor-excited and nonlocomotor-related striatal neurons in aged F344 rats John A. Stanford, Michael F. Salvatore, B. Matthew Joyce, Neurobiology of Aging NeurophysiologyNeuroanatomyUnilateral Intrastriatal GdnfPhysiologyBilateral Effects	2005	17
Targeting Reward-Relevant Nicotinic Receptors in the Discovery of Novel Pharmacotherapeutic Agents to Treat Tobacco Dependence Linda P. Dwoskin, Marharyta Pivavarchyk, B. Matthew Joyce, Nebraska Symposium on Motivation/The Nebraska symposium on motivation	2008	11
Discovery of a novel nicotinic receptor antagonist for the treatment of nicotine addiction: 1-(3-Picolinium)-12-triethylammonium-dodecane dibromide (TMPD) Linda P. Dwoskin, B. Matthew Joyce, Guangrong Zheng, Biochemical Pharmacology Psychoactive DrugFunctional SelectivityAddictionNicotinePharmacology	2007	10

Page 1